ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
ENSG00000132718.8,SYT11 | BLCA | EAG | Plasma_cells | 8.9324e-03 | 0.4480 |  |
chr1:155883229-155883509:+ | BRCA | EER | Neutrophils | 2.2774e-02 | 0.1688 |  |
ENSG00000132718.8,SYT11 | BRCA | EAG | T_cells_CD4_naive | 1.1717e-02 | 0.1478 |  |
ENSG00000132718.8,SYT11 | CESC | EAG | T_cells_gamma_delta | 3.9323e-02 | 0.4527 |  |
ENSG00000132718.8,SYT11 | ESCA | EAG | NK_cells_activated | 2.1086e-02 | 0.2835 |  |
ENSG00000132718.8,SYT11 | GBM | EAG | Monocytes | 4.0032e-04 | 0.2941 |  |
ENSG00000132718.8,SYT11 | HNSC | EAG | Mast_cells_activated | 5.5579e-03 | 0.3352 |  |
ENSG00000132718.8,SYT11 | KIRC | EAG | Plasma_cells | 8.3585e-05 | 0.3023 |  |
ENSG00000132718.8,SYT11 | KIRP | EAG | Eosinophils | 5.4075e-06 | 0.4612 |  |
ENSG00000132718.8,SYT11 | LGG | EAG | Mast_cells_activated | 4.1695e-03 | -0.1603 |  |
ENSG00000132718.8,SYT11 | LUAD | EAG | Dendritic_cells_activated | 2.9345e-03 | 0.3005 |  |
chr1:155883229-155883509:+ | MESO | EER | B_cells_memory | 3.3026e-02 | 0.4665 |  |
ENSG00000132718.8,SYT11 | MESO | EAG | Eosinophils | 4.8088e-02 | 0.4164 |  |
chr1:155881779-155882052:+ | OV | EER | T_cells_gamma_delta | 3.6804e-02 | 0.1695 |  |
ENSG00000132718.8,SYT11 | OV | EAG | Macrophages_M2 | 1.7129e-03 | -0.2022 |  |
ENSG00000132718.8,SYT11 | PAAD | EAG | Macrophages_M0 | 4.3692e-04 | 0.4433 |  |
chr1:155883229-155883509:+ | PRAD | EER | Monocytes | 9.9533e-04 | -0.3702 |  |
ENSG00000132718.8,SYT11 | PRAD | EAG | Monocytes | 1.9852e-03 | -0.2944 |  |
chr1:155883229-155883509:+ | SARC | EER | T_cells_CD4_memory_activated | 1.2732e-02 | 0.2483 |  |
ENSG00000132718.8,SYT11 | SKCM | EAG | NK_cells_activated | 4.9939e-02 | 0.1432 |  |
chr1:155881779-155882052:+ | STAD | EER | Neutrophils | 6.0936e-03 | 0.2460 |  |
ENSG00000132718.8,SYT11 | STAD | EAG | T_cells_CD4_memory_activated | 1.1249e-03 | 0.2376 |  |
ENSG00000132718.8,SYT11 | THCA | EAG | Neutrophils | 3.4306e-03 | 0.2872 |  |
chr1:155883229-155883509:+ | UCEC | EER | Dendritic_cells_activated | 2.3342e-03 | 0.4624 |  |
ENSG00000132718.8,SYT11 | UCEC | EAG | Dendritic_cells_activated | 1.5213e-03 | 0.4409 |  |
ENSG00000132718.8,SYT11 | UCS | EAG | T_cells_CD8 | 3.4781e-02 | 0.4155 |  |
ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
ENSG00000132718.8,SYT11 | BLCA | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EAG | 2.3416e-03 | -0.5116 |  |
chr1:155883229-155883509:+ | BRCA | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EER | 9.1620e-06 | 0.3222 |  |
ENSG00000132718.8,SYT11 | BRCA | GSVA_HALLMARK_UV_RESPONSE_DN | EAG | 8.2925e-07 | -0.2846 |  |
ENSG00000132718.8,SYT11 | ESCA | GSVA_HALLMARK_COAGULATION | EAG | 3.9967e-02 | -0.2535 |  |
ENSG00000132718.8,SYT11 | GBM | GSVA_HALLMARK_BILE_ACID_METABOLISM | EAG | 3.9040e-07 | 0.4118 |  |
ENSG00000132718.8,SYT11 | HNSC | GSVA_HALLMARK_ALLOGRAFT_REJECTION | EAG | 1.6288e-04 | -0.4447 |  |
ENSG00000132718.8,SYT11 | KIRC | GSVA_HALLMARK_HEDGEHOG_SIGNALING | EAG | 2.4795e-09 | -0.4445 |  |
ENSG00000132718.8,SYT11 | KIRP | GSVA_HALLMARK_TGF_BETA_SIGNALING | EAG | 1.3165e-03 | -0.3353 |  |
ENSG00000132718.8,SYT11 | LGG | GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE | EAG | 1.1009e-12 | 0.3851 |  |
ENSG00000132718.8,SYT11 | LUAD | GSVA_HALLMARK_HEDGEHOG_SIGNALING | EAG | 7.5269e-03 | -0.2712 |  |
ENSG00000132718.8,SYT11 | LUSC | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EAG | 3.3644e-02 | 0.2137 |  |
ENSG00000132718.8,SYT11 | MESO | GSVA_HALLMARK_P53_PATHWAY | EAG | 8.8521e-03 | 0.5328 |  |
chr1:155883229-155883509:+ | MESO | GSVA_HALLMARK_P53_PATHWAY | EER | 1.2681e-02 | 0.5339 |  |
chr1:155881779-155882052:+ | OV | GSVA_HALLMARK_MITOTIC_SPINDLE | EER | 4.6223e-02 | -0.1620 |  |
ENSG00000132718.8,SYT11 | OV | GSVA_HALLMARK_HEDGEHOG_SIGNALING | EAG | 3.3624e-09 | -0.3714 |  |
ENSG00000132718.8,SYT11 | PAAD | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EAG | 4.3299e-02 | -0.2640 |  |
chr1:155883229-155883509:+ | PCPG | GSVA_HALLMARK_UV_RESPONSE_DN | EER | 6.7640e-03 | -0.3143 |  |
ENSG00000132718.8,SYT11 | PCPG | GSVA_HALLMARK_UV_RESPONSE_DN | EAG | 1.1463e-03 | -0.3660 |  |
chr1:155883229-155883509:+ | PRAD | GSVA_HALLMARK_UV_RESPONSE_DN | EER | 2.0498e-05 | -0.4676 |  |
ENSG00000132718.8,SYT11 | PRAD | GSVA_HALLMARK_UV_RESPONSE_DN | EAG | 2.4226e-07 | -0.4725 |  |
chr1:155883229-155883509:+ | SARC | GSVA_HALLMARK_APICAL_SURFACE | EER | 5.5393e-03 | 0.2755 |  |
ENSG00000132718.8,SYT11 | SARC | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EAG | 4.9678e-02 | 0.1885 |  |
chr1:155883229-155883509:+ | SKCM | GSVA_HALLMARK_UV_RESPONSE_DN | EER | 1.9729e-04 | -0.2920 |  |
ENSG00000132718.8,SYT11 | SKCM | GSVA_HALLMARK_UV_RESPONSE_DN | EAG | 1.0972e-03 | -0.2363 |  |
chr1:155881779-155882052:+ | STAD | GSVA_HALLMARK_HEDGEHOG_SIGNALING | EER | 1.2497e-04 | -0.3390 |  |
ENSG00000132718.8,SYT11 | STAD | GSVA_HALLMARK_HEDGEHOG_SIGNALING | EAG | 3.5300e-04 | -0.2599 |  |
ENSG00000132718.8,SYT11 | THCA | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EAG | 8.1553e-03 | 0.2606 |  |
ENSG00000132718.8,SYT11 | UCEC | GSVA_HALLMARK_MYOGENESIS | EAG | 3.1509e-02 | -0.3077 |  |
chr1:155883229-155883509:+ | UCEC | GSVA_HALLMARK_MYOGENESIS | EER | 2.2602e-02 | -0.3554 |  |
ENSG00000132718.8,SYT11 | UCS | GSVA_HALLMARK_HEDGEHOG_SIGNALING | EAG | 2.4511e-03 | -0.5684 |  |
ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
ENSG00000132718.8,SYT11 | BLCA | GW.441756 | EAG | 2.8142e-02 | -0.3822 |  |
chr1:155883229-155883509:+ | BRCA | DMOG | EER | 3.3723e-05 | 0.3030 |  |
ENSG00000132718.8,SYT11 | BRCA | DMOG | EAG | 2.6067e-05 | 0.2447 |  |
ENSG00000132718.8,SYT11 | CESC | AMG.706 | EAG | 2.5367e-02 | 0.4982 |  |
ENSG00000132718.8,SYT11 | ESCA | BIBW2992 | EAG | 2.1116e-02 | -0.2834 |  |
ENSG00000132718.8,SYT11 | GBM | CEP.701 | EAG | 2.8967e-09 | 0.4740 |  |
ENSG00000132718.8,SYT11 | HNSC | AP.24534 | EAG | 2.0472e-05 | 0.4951 |  |
ENSG00000132718.8,SYT11 | KIRC | Embelin | EAG | 3.0430e-08 | 0.4159 |  |
ENSG00000132718.8,SYT11 | KIRP | AZD6482 | EAG | 1.6850e-03 | 0.3283 |  |
ENSG00000132718.8,SYT11 | LGG | Bortezomib | EAG | 7.6965e-16 | -0.4313 |  |
ENSG00000132718.8,SYT11 | LUAD | GSK269962A | EAG | 2.2960e-03 | 0.3108 |  |
ENSG00000132718.8,SYT11 | LUSC | Lapatinib | EAG | 3.7772e-02 | -0.2102 |  |
ENSG00000132718.8,SYT11 | MESO | Embelin | EAG | 4.2638e-03 | 0.5730 |  |
chr1:155883229-155883509:+ | MESO | Cyclopamine | EER | 5.5578e-03 | 0.5828 |  |
chr1:155881779-155882052:+ | OV | AZD6244 | EER | 4.5633e-03 | -0.2289 |  |
ENSG00000132718.8,SYT11 | OV | Bexarotene | EAG | 4.4354e-08 | 0.3456 |  |
ENSG00000132718.8,SYT11 | PAAD | BIBW2992 | EAG | 8.1412e-03 | -0.3414 |  |
chr1:155883229-155883509:+ | PCPG | BMS.536924 | EER | 3.2266e-02 | -0.2526 |  |
ENSG00000132718.8,SYT11 | PCPG | Gefitinib | EAG | 1.9221e-02 | -0.2681 |  |
chr1:155883229-155883509:+ | PRAD | BX.795 | EER | 1.9235e-04 | 0.4151 |  |
ENSG00000132718.8,SYT11 | PRAD | BX.795 | EAG | 3.2030e-05 | 0.3888 |  |
chr1:155883229-155883509:+ | SARC | Camptothecin | EER | 1.8476e-04 | -0.3655 |  |
ENSG00000132718.8,SYT11 | SARC | Cytarabine | EAG | 2.7448e-03 | -0.2842 |  |
chr1:155883229-155883509:+ | SKCM | GNF.2 | EER | 1.4974e-05 | -0.3369 |  |
ENSG00000132718.8,SYT11 | SKCM | GNF.2 | EAG | 5.4799e-05 | -0.2898 |  |
chr1:155881779-155882052:+ | STAD | BIBW2992 | EER | 1.4353e-07 | -0.4564 |  |
ENSG00000132718.8,SYT11 | STAD | AZD6482 | EAG | 7.0541e-05 | 0.2880 |  |
ENSG00000132718.8,SYT11 | THCA | Etoposide | EAG | 1.2366e-03 | 0.3155 |  |
ENSG00000132718.8,SYT11 | UCEC | Lapatinib | EAG | 2.3339e-03 | -0.4250 |  |
chr1:155883229-155883509:+ | UCEC | Lapatinib | EER | 2.4688e-03 | -0.4602 |  |
ENSG00000132718.8,SYT11 | UCS | BX.795 | EAG | 5.6413e-03 | 0.5273 |  |